FDA grants breakthrough device designation to MeMed sepsis test

The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to MeMed for its rapid diagnostic and risk...
4 days ago
from: LabPulse.com

Food and Drug Administration, Medicine, Sepsis

More about this

- FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
This designation advances the management of acute infections and sepsis by empowering clinicians with timely insights for better patient...
from: Business Wire

- MeMed’s Severity Test for Suspected Sepsis Gains FDA Breakthrough Status
The Severity test measures multiple proteins from a blood sample and leverages machine learning to stratify risk of patient deterioration.
from: Medical Product Outsourcing